about
Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?Molecular epidemiology, drug susceptibility and economic aspects of tuberculosis in Mubende district, UgandaA comparison of tools used for tuberculosis diagnosis in resource-limited settings: a case study at Mubende referral hospital, UgandaGenomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.Patient satisfaction with TB care clinical consultations in Kampala: a cross sectional studyComparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individualsProspective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosisEvaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB settingCost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda.Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.Incremental yield of serial sputum cultures for diagnosis of tuberculosis among HIV infected smear negative pulmonary TB suspects in Kampala, Uganda.High incidence of pulmonary tuberculosis in children admitted with severe pneumonia in UgandaSpecies and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda.Burden of tuberculosis disease among adolescents in a rural cohort in Eastern Uganda.Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation.Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals.Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic TechnologyWhole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients.Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda.An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda.Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda.Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study.Whole genome sequencing to complement tuberculosis drug resistance surveys in UgandaSensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugsMycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.Molecular investigation of multiple strain infections in patients with tuberculosis in Mubende district, Uganda.Performance of loop-mediated isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda.Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.Prevalence of Tuberculosis Risk Factors among Bacteriologically Negative and Bacteriologically Confirmed Tuberculosis Patients from Five Regional Referral Hospitals in UgandaXpert MTB/RIF Ultra: Optimal procedures for the detection of Mycobacterium tuberculosis in cerebrospinal fluidComparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional studyVariable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistanceXpert MTB/RIF Ultra for Detection of Mycobacterium tuberculosis in Cerebrospinal Fluid
P50
Q28389038-8207E117-D1D1-42E7-96DB-771DF719C839Q28533540-331F85D9-8561-4ADD-82AA-AC08F8E49731Q28540059-750F9742-5315-4F72-94C5-876983E9AF57Q33595994-8CC99B43-613D-429F-B9EC-04C9B7D529CFQ33739477-B894DF1F-B51B-419C-9E9D-85C71D070393Q33820488-E21376AF-7615-45C7-B4AF-2E319B98C7F0Q33899999-C0636A49-0FE7-4D13-85C4-FE4C70C5023CQ33933436-00AFD02F-F4DF-49FC-A413-21AB580BB8E6Q34048848-13109464-9D26-4D59-8B18-49E56EFB0D9FQ34184138-9C58D726-9D5C-43B5-9279-73510D9C6E1AQ34184508-AE4143B5-1547-4F4A-8341-C82EA9AFE3EEQ34282121-119224B5-0329-42EC-88F8-886CB34E7FC8Q34569606-9BC5DF9E-B2B4-4B52-8066-04FC4F176563Q34588310-933DBCA1-4D77-420A-B14B-3B91B8F5C05FQ34869423-54B17326-9BA7-487A-89FA-8B81F42F73E8Q35030196-423603D6-2256-4B42-9404-AC55298BB157Q35078481-9918BF98-0B67-4618-94EE-7560D14D6F75Q35094781-3F0DE93A-D130-4C80-B486-93F6D298212BQ35193361-0E4ED470-388C-4979-8066-B6AAC50C6080Q35546001-B26F15A8-D7BD-4E36-91EF-F1F987F9813BQ35691978-0771CE20-3E45-48B2-BC39-F879C7AC451AQ35722812-A418C8BE-E1E3-4A8D-A441-8D67BD3317F9Q36096208-824BED83-8EFA-4E63-B5FE-34B858C19A5BQ36185995-49498734-5FE9-4A3D-8D69-5E1183F8B15EQ36486323-5023505E-21B7-43D4-BFC5-64A2D5554481Q36612697-5EC6097B-03C0-47B2-A591-1CA5E322CAE5Q36699672-BFC28D3C-42F4-40A9-8A56-78725FF2C3A3Q36869848-D0CBF704-0F9B-4582-90C7-07B1ED686C74Q37544293-C5A4F753-C5BB-40A7-B50D-9C1CB12FFD4DQ37588147-42549FD9-C888-4D1E-81D6-C8265C9C542EQ38841841-8477C5C4-D2DA-4865-BDC6-E43E5AC1AE43Q38865660-2633A884-3EE1-4A0D-AE37-B77F2F17B87EQ50306870-295CAE0C-CFD2-41A9-A152-DD3EB29CE8B8Q55001966-AD9749B8-8097-43FE-9B93-7BAB2F4723B7Q55451060-5F5FCC87-42D0-4524-B0C6-B27C4CE515A1Q90802595-1296FDB1-0D3F-4F2F-BCF5-5A4184083B72Q91263031-402FADDB-EC02-47BE-AFB2-DEEC61AB90F5Q92039649-EEFA3128-9D3F-41D9-ACFF-DBFC0E1E9B09Q92624648-C316B5F9-AB14-48F1-9C06-0555143D802CQ92828232-18A257CA-D8A5-4C4F-B105-D8C1956F94E4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Willy Ssengooba
@ast
Willy Ssengooba
@en
Willy Ssengooba
@es
Willy Ssengooba
@nl
type
label
Willy Ssengooba
@ast
Willy Ssengooba
@en
Willy Ssengooba
@es
Willy Ssengooba
@nl
prefLabel
Willy Ssengooba
@ast
Willy Ssengooba
@en
Willy Ssengooba
@es
Willy Ssengooba
@nl
P106
P1153
55223995000
P21
P31
P496
0000-0002-1643-110X